Hypoimmune-modified allogeneic iPSCs evade immune response and rejection without immunosuppression in non-human primate model Long-term survival and immune evasion of hypoimmune-modified allogeneic. | May 8, 2023
/PRNewswire/ Vade, a global cybersecurity company specializing in securing human collaboration, today announced that René Bonvanie has joined the company as.